GrayBug names new business development head
GrayBug, a company developing drug delivery systems and drugs to more effectively treat eye disease, has announced Gerald D. Cagle, Ph.D., has joined GrayBug as a senior advisor and head of business development.
Cagle is a pharmaceutical executive with over 35 years of managerial, technical and business experience. During the last 13 years at Alcon, he was senior vice president and chief scientific officer. Also at Alcon he was a laboratory scientist and worked in clinical research, regulatory affairs and product development.
While at Alcon, Cagle either directed or was a contributing author of numerous NDAs and premarket approvals (PMAs), from which more than 100 new Alcon products were achieved.